Adiponectin and its receptors in chronic hepatitis B patients with metabolic syndrome in China

Xin Li, Na Ren, Wei Ling, Feng Xin Chen, Wei Yan Zhang, Xiao Ling Fan, Mei Mei Tian, Ting Zhang, Ben Li, Lawrence Pfeffer, Hao Wu, Jin Qian Zhang

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Background/Aims: Adiponectin can initiate a broad range of metabolic and immunological effects. Little is known about the role of adiponectin in hepatitis B-related liver disease and metabolic syndrome (MS). Methodology: We studied 138 patients with untreated chronic hepatitis B (CHB), who were from Beijing Ditan hospital in 2005 to 2009. According to MS, two groups (65 with MS vs. 73 without MS) were established. They were compared with characteristics and stained immunohistochemically for adiponectin and adiponectin receptor2 (adipoR2). Results: In the group of CHB patients with MS, the levels of LDH, γ-GT, FPG, FINS, HOMA-IR, HOMA-β, TG and HBeAg positive were significantly higher than those in the group without MS (p<0.05). Liver steatosis in the group with MS is significantly more severe than that in the group without MS (p<0.001). With binary logistic regression analyses, BMI and HOMA-IR showed independent predictors to MS in patients with CHB. In patients with chronic HBV, the insulin sensitizing adipokine adiponectin and its receptor AdipoR2 was associated with diabetes in patients with CHB and MS. Conclusions: Our findings showed the CHB patients with MS may be presence of more severe steatosis. MS in CHB patients may be closely correlated with insulin resistance and less effect of viruses. Reduced hepatic expression of adiponectin and adipoR2 might be of pathophysiological relevance in CHB patients with MS.

Original languageEnglish (US)
Pages (from-to)1735-1743
Number of pages9
JournalHepato-Gastroenterology
Volume59
Issue number118
DOIs
StatePublished - Sep 1 2012

Fingerprint

Adiponectin Receptors
Chronic Hepatitis B
China
Adiponectin
Adipokines
Hepatitis B e Antigens
Fatty Liver
Hepatitis B

All Science Journal Classification (ASJC) codes

  • Hepatology
  • Gastroenterology

Cite this

Li, X., Ren, N., Ling, W., Chen, F. X., Zhang, W. Y., Fan, X. L., ... Zhang, J. Q. (2012). Adiponectin and its receptors in chronic hepatitis B patients with metabolic syndrome in China. Hepato-Gastroenterology, 59(118), 1735-1743. https://doi.org/10.5754/hge10717

Adiponectin and its receptors in chronic hepatitis B patients with metabolic syndrome in China. / Li, Xin; Ren, Na; Ling, Wei; Chen, Feng Xin; Zhang, Wei Yan; Fan, Xiao Ling; Tian, Mei Mei; Zhang, Ting; Li, Ben; Pfeffer, Lawrence; Wu, Hao; Zhang, Jin Qian.

In: Hepato-Gastroenterology, Vol. 59, No. 118, 01.09.2012, p. 1735-1743.

Research output: Contribution to journalArticle

Li, X, Ren, N, Ling, W, Chen, FX, Zhang, WY, Fan, XL, Tian, MM, Zhang, T, Li, B, Pfeffer, L, Wu, H & Zhang, JQ 2012, 'Adiponectin and its receptors in chronic hepatitis B patients with metabolic syndrome in China', Hepato-Gastroenterology, vol. 59, no. 118, pp. 1735-1743. https://doi.org/10.5754/hge10717
Li, Xin ; Ren, Na ; Ling, Wei ; Chen, Feng Xin ; Zhang, Wei Yan ; Fan, Xiao Ling ; Tian, Mei Mei ; Zhang, Ting ; Li, Ben ; Pfeffer, Lawrence ; Wu, Hao ; Zhang, Jin Qian. / Adiponectin and its receptors in chronic hepatitis B patients with metabolic syndrome in China. In: Hepato-Gastroenterology. 2012 ; Vol. 59, No. 118. pp. 1735-1743.
@article{2f1ed41690c44c4c9ff9991a8c635ac6,
title = "Adiponectin and its receptors in chronic hepatitis B patients with metabolic syndrome in China",
abstract = "Background/Aims: Adiponectin can initiate a broad range of metabolic and immunological effects. Little is known about the role of adiponectin in hepatitis B-related liver disease and metabolic syndrome (MS). Methodology: We studied 138 patients with untreated chronic hepatitis B (CHB), who were from Beijing Ditan hospital in 2005 to 2009. According to MS, two groups (65 with MS vs. 73 without MS) were established. They were compared with characteristics and stained immunohistochemically for adiponectin and adiponectin receptor2 (adipoR2). Results: In the group of CHB patients with MS, the levels of LDH, γ-GT, FPG, FINS, HOMA-IR, HOMA-β, TG and HBeAg positive were significantly higher than those in the group without MS (p<0.05). Liver steatosis in the group with MS is significantly more severe than that in the group without MS (p<0.001). With binary logistic regression analyses, BMI and HOMA-IR showed independent predictors to MS in patients with CHB. In patients with chronic HBV, the insulin sensitizing adipokine adiponectin and its receptor AdipoR2 was associated with diabetes in patients with CHB and MS. Conclusions: Our findings showed the CHB patients with MS may be presence of more severe steatosis. MS in CHB patients may be closely correlated with insulin resistance and less effect of viruses. Reduced hepatic expression of adiponectin and adipoR2 might be of pathophysiological relevance in CHB patients with MS.",
author = "Xin Li and Na Ren and Wei Ling and Chen, {Feng Xin} and Zhang, {Wei Yan} and Fan, {Xiao Ling} and Tian, {Mei Mei} and Ting Zhang and Ben Li and Lawrence Pfeffer and Hao Wu and Zhang, {Jin Qian}",
year = "2012",
month = "9",
day = "1",
doi = "10.5754/hge10717",
language = "English (US)",
volume = "59",
pages = "1735--1743",
journal = "Acta hepato-splenologica",
issn = "0172-6390",
publisher = "H.G.E. Update Medical Publishing Ltd.",
number = "118",

}

TY - JOUR

T1 - Adiponectin and its receptors in chronic hepatitis B patients with metabolic syndrome in China

AU - Li, Xin

AU - Ren, Na

AU - Ling, Wei

AU - Chen, Feng Xin

AU - Zhang, Wei Yan

AU - Fan, Xiao Ling

AU - Tian, Mei Mei

AU - Zhang, Ting

AU - Li, Ben

AU - Pfeffer, Lawrence

AU - Wu, Hao

AU - Zhang, Jin Qian

PY - 2012/9/1

Y1 - 2012/9/1

N2 - Background/Aims: Adiponectin can initiate a broad range of metabolic and immunological effects. Little is known about the role of adiponectin in hepatitis B-related liver disease and metabolic syndrome (MS). Methodology: We studied 138 patients with untreated chronic hepatitis B (CHB), who were from Beijing Ditan hospital in 2005 to 2009. According to MS, two groups (65 with MS vs. 73 without MS) were established. They were compared with characteristics and stained immunohistochemically for adiponectin and adiponectin receptor2 (adipoR2). Results: In the group of CHB patients with MS, the levels of LDH, γ-GT, FPG, FINS, HOMA-IR, HOMA-β, TG and HBeAg positive were significantly higher than those in the group without MS (p<0.05). Liver steatosis in the group with MS is significantly more severe than that in the group without MS (p<0.001). With binary logistic regression analyses, BMI and HOMA-IR showed independent predictors to MS in patients with CHB. In patients with chronic HBV, the insulin sensitizing adipokine adiponectin and its receptor AdipoR2 was associated with diabetes in patients with CHB and MS. Conclusions: Our findings showed the CHB patients with MS may be presence of more severe steatosis. MS in CHB patients may be closely correlated with insulin resistance and less effect of viruses. Reduced hepatic expression of adiponectin and adipoR2 might be of pathophysiological relevance in CHB patients with MS.

AB - Background/Aims: Adiponectin can initiate a broad range of metabolic and immunological effects. Little is known about the role of adiponectin in hepatitis B-related liver disease and metabolic syndrome (MS). Methodology: We studied 138 patients with untreated chronic hepatitis B (CHB), who were from Beijing Ditan hospital in 2005 to 2009. According to MS, two groups (65 with MS vs. 73 without MS) were established. They were compared with characteristics and stained immunohistochemically for adiponectin and adiponectin receptor2 (adipoR2). Results: In the group of CHB patients with MS, the levels of LDH, γ-GT, FPG, FINS, HOMA-IR, HOMA-β, TG and HBeAg positive were significantly higher than those in the group without MS (p<0.05). Liver steatosis in the group with MS is significantly more severe than that in the group without MS (p<0.001). With binary logistic regression analyses, BMI and HOMA-IR showed independent predictors to MS in patients with CHB. In patients with chronic HBV, the insulin sensitizing adipokine adiponectin and its receptor AdipoR2 was associated with diabetes in patients with CHB and MS. Conclusions: Our findings showed the CHB patients with MS may be presence of more severe steatosis. MS in CHB patients may be closely correlated with insulin resistance and less effect of viruses. Reduced hepatic expression of adiponectin and adipoR2 might be of pathophysiological relevance in CHB patients with MS.

UR - http://www.scopus.com/inward/record.url?scp=84867740042&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84867740042&partnerID=8YFLogxK

U2 - 10.5754/hge10717

DO - 10.5754/hge10717

M3 - Article

VL - 59

SP - 1735

EP - 1743

JO - Acta hepato-splenologica

JF - Acta hepato-splenologica

SN - 0172-6390

IS - 118

ER -